Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

NCT01937338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

LPS Challenge, Neutrophils

Interventions

DRUG: AZD7624
DRUG: Placebo

Sponsor

AstraZeneca